Cargando…

Impact of chronic kidney disease on the diuretic response of tolvaptan in acute decompensated heart failure

AIM: This study investigated the relationship between the initial diuretic response to tolvaptan and clinical predictors for tolvaptan responders in patients with acute decompensated heart failure (ADHF). METHODS AND RESULTS: Patients (153) with ADHF (clinical scenario 2 or 3 with signs of fluid ret...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikeda, Shuntaro, Ohshima, Kiyotaka, Miyazaki, Shigehiro, Kadota, Hisaki, Shimizu, Hideaki, Ogimoto, Akiyoshi, Hamada, Mareomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695178/ https://www.ncbi.nlm.nih.gov/pubmed/29154417 http://dx.doi.org/10.1002/ehf2.12190

Ejemplares similares

Impact of cibenzoline treatment on left ventricular remodelling and prognosis in hypertrophic obstructive cardiomyopathy
por: Hamada, Mareomi, et al.
Publicado: (2021)

Predicting the clinical course in hypertrophic cardiomyopathy using thallium‐201 myocardial scintigraphy
por: Hamada, Mareomi, et al.
Publicado: (2021)

Renoprotective Benefit of Tolvaptan in Acute Decompensated Heart Failure Patients With Loop Diuretic-Resistant Status
por: Yamamoto, Tomohiko, et al.
Publicado: (2019)

Extracardiac Tumor from Duodenal Primary Gastrointestinal Stromal Tumor
por: Miyazaki, Shigehiro, et al.
Publicado: (2017)

Tolvaptan: A Novel Diuretic in Heart Failure Management
por: Zulkifli Amin, Hilman, et al.
Publicado: (2016)

Transmitral Doppler Flow Pattern in Left Atrial Myxoma
por: Hamada, Mareomi, et al.
Publicado: (2018)

Long-Term Tolvaptan Treatment in Refractory Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2019)

Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction
por: Matsue, Yuya, et al.
Publicado: (2017)

Prognostic Impact of the Early Use of Tolvaptan in Elderly Patients with Acute Decompensated Heart Failure
por: Okada, Tomoaki, et al.
Publicado: (2023)

Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic‐refractory congestive heart failure: the SEMI‐SEC project
por: Pose, Antonio, et al.
Publicado: (2017)

Tolvaptan vs. furosemide‐based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA‐AHF)
por: Ng, Tien M.H., et al.
Publicado: (2020)

Effect of diuretic infusion clinic in preventing hospitalization for patients with decompensating heart failure
por: Alghalayini, Kamal Waheeb
Publicado: (2020)

Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure
por: Yoshioka, Kenji, et al.
Publicado: (2022)

Clinical utility of early use of tolvaptan in very elderly patients with acute decompensated heart failure
por: Niikura, Hiroki, et al.
Publicado: (2017)

Tolvaptan in the very elderly with acute decompensated heart failure-a therapeutic option worth of consideration
por: Ndrepepa, Gjin
Publicado: (2017)

Hemodynamic and Hormonal Effects of Tolvaptan for Heart Failure
por: Kiuchi, Shunsuke, et al.
Publicado: (2018)

High-Sensitivity Troponin T: A Biomarker for Diuretic Response in Decompensated Heart Failure Patients
por: Ferreira, João Pedro, et al.
Publicado: (2014)

Triple Diuretics and Aquaretic Strategy for Acute Decompensated Heart Failure due to Volume Overload
por: Jermyn, Rita, et al.
Publicado: (2013)

Trial of Oral Diuretics Prior to Discharge Is Not Associated With Improved Outcomes in Decompensated Heart Failure
por: Mohammad, Adeba, et al.
Publicado: (2021)

Long-term administration of Tolvaptan to patients with decompensated cirrhosis
por: Kanayama, Kengo, et al.
Publicado: (2020)

Risk and protective factors of acute kidney injury in decompensated cirrhotic patients with ascites on tolvaptan
por: Kogiso, Tomomi, et al.
Publicado: (2021)

Effect of Tolvaptan in Patients with Chronic Kidney Disease Stage G5, and Impact of Concomitant Use of Thiazide Diuretics: A Retrospective Cohort Study
por: Uchiyama, Kiyotaka, et al.
Publicado: (2022)

Case report: a thiazide diuretic to treat polyuria induced by tolvaptan
por: Kramers, Bart J., et al.
Publicado: (2018)

Great debate: in patients with decompensated heart failure, acetazolamide in addition to loop diuretics is the first choice
por: Mullens, Wilfried, et al.
Publicado: (2023)

Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011)

A novel validated method for predicting the risk of re-hospitalization for worsening heart failure and the effectiveness of the diuretic upgrading therapy with tolvaptan
por: Takimura, Hideyuki, et al.
Publicado: (2018)

Tolvaptan Add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction (DR-AHF): Design and Rationale
por: Minh, Nhat Giang, et al.
Publicado: (2022)

Point-of-Care, Ultraportable Echocardiography Predicts Diuretic Response in Patients Admitted with Acute Decompensated Heart Failure
por: Krishnan, Dena K., et al.
Publicado: (2016)

Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure
por: Katsumata, Mari, et al.
Publicado: (2017)

Correlation between plaque vulnerability of aorta and coronary artery: an evaluation of plaque activity by direct visualization with angioscopy
por: Aono, Jun, et al.
Publicado: (2015)

Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome—an analysis from RELAX-AHF
por: Voors, Adriaan A, et al.
Publicado: (2014)

Six-Month Predictive Value of Diuretic Resistance Formulas in Discharged Heart Failure Patients after an Acute Decompensation
por: Feola, Mauro, et al.
Publicado: (2020)

Sodium glucose cotransporter 2 inhibitors as diuretic adjuvants in acute decompensated heart failure: a case series
por: Griffin, Matthew, et al.
Publicado: (2020)

Patients with high-dose diuretics should get ultrafiltration in the management of decompensated heart failure: a meta-analysis
por: Shi, Xiaofeng, et al.
Publicado: (2019)

Vanishing Cardiac Tumor by Chemotherapy in a Patient With Diffuse Large B-Cell Lymphoma
por: Watanabe, Yuta, et al.
Publicado: (2021)

Tolvaptan-induced hypernatremia related to low serum potassium level accompanying high blood pressure in patients with acute decompensated heart failure
por: Fukuoka, Hidetada, et al.
Publicado: (2020)

Meta-Analysis of Ultrafiltration versus Diuretics Treatment Option for Overload Volume Reduction in Patients with Acute Decompensated Heart Failure
por: Barkoudah, Ebrahim, et al.
Publicado: (2015)

Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial
por: Palazzuoli, Alberto, et al.
Publicado: (2014)

Effects of early diuretic response to carperitide in acute decompensated heart failure treatment: A single-center retrospective study
por: Okuhara, Yoshitaka, et al.
Publicado: (2018)

Diuretic Resistance in Heart Failure
por: Gupta, Richa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0p03lidroa3sk2ucvgancblkun